Annual Operating Expenses
$60.42 M
+$9.16 M+17.88%
December 31, 2023
Summary
- As of March 8, 2025, OPRX annual total operating expenses is $60.42 million, with the most recent change of +$9.16 million (+17.88%) on December 31, 2023.
- During the last 3 years, OPRX annual operating expenses has risen by +$34.18 million (+130.26%).
- OPRX annual operating expenses is now at all-time high.
Performance
OPRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$14.52 M
-$933.00 K-6.04%
September 30, 2024
Summary
- As of March 8, 2025, OPRX quarterly total operating expenses is $14.52 million, with the most recent change of -$933.00 thousand (-6.04%) on September 30, 2024.
- Over the past year, OPRX quarterly operating expenses has increased by +$1.17 million (+8.74%).
- OPRX quarterly operating expenses is now -26.91% below its all-time high of $19.86 million, reached on December 31, 2023.
Performance
OPRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
OPRX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | +8.7% |
| 3 y3 years | +130.3% | +23.4% |
| 5 y5 years | +429.1% | +142.3% |
OPRX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.3% | -26.9% | +23.4% |
| 5 y | 5-year | at high | +229.6% | -26.9% | +142.3% |
| alltime | all time | at high | >+9999.0% | -26.9% | +8835.4% |
OptimizeRx Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.52 M(-6.0%) |
| Jun 2024 | - | $15.45 M(-10.3%) |
| Mar 2024 | - | $17.23 M(-13.2%) |
| Dec 2023 | $60.42 M(+17.9%) | $19.86 M(+48.8%) |
| Sep 2023 | - | $13.35 M(+5.4%) |
| Jun 2023 | - | $12.67 M(-12.6%) |
| Mar 2023 | - | $14.50 M(+8.8%) |
| Dec 2022 | $51.26 M(+45.3%) | $13.32 M(+1.1%) |
| Sep 2022 | - | $13.18 M(+2.2%) |
| Jun 2022 | - | $12.90 M(+8.7%) |
| Mar 2022 | - | $11.86 M(+0.8%) |
| Dec 2021 | $35.28 M(+34.4%) | $11.77 M(+30.2%) |
| Sep 2021 | - | $9.04 M(+17.3%) |
| Jun 2021 | - | $7.70 M(+13.9%) |
| Mar 2021 | - | $6.76 M(-6.7%) |
| Dec 2020 | $26.24 M(+43.1%) | $7.25 M(+17.1%) |
| Sep 2020 | - | $6.19 M(-0.1%) |
| Jun 2020 | - | $6.20 M(-6.1%) |
| Mar 2020 | - | $6.60 M(+10.2%) |
| Dec 2019 | $18.33 M(+60.6%) | $5.99 M(+19.6%) |
| Sep 2019 | - | $5.01 M(+30.5%) |
| Jun 2019 | - | $3.84 M(+9.9%) |
| Mar 2019 | - | $3.49 M(-4.5%) |
| Dec 2018 | $11.42 M(+41.3%) | $3.66 M(+27.1%) |
| Sep 2018 | - | $2.88 M(+11.1%) |
| Jun 2018 | - | $2.59 M(+12.8%) |
| Mar 2018 | - | $2.30 M(-16.9%) |
| Dec 2017 | $8.08 M(+37.7%) | $2.76 M(+36.2%) |
| Sep 2017 | - | $2.03 M(+24.4%) |
| Jun 2017 | - | $1.63 M(-1.8%) |
| Mar 2017 | - | $1.66 M(-12.5%) |
| Dec 2016 | $5.87 M | $1.90 M(+44.7%) |
| Sep 2016 | - | $1.31 M(-8.4%) |
| Jun 2016 | - | $1.43 M(+16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $1.23 M(-17.9%) |
| Dec 2015 | $4.20 M(+7.4%) | $1.50 M(+71.0%) |
| Sep 2015 | - | $875.40 K(-10.7%) |
| Jun 2015 | - | $980.70 K(+16.4%) |
| Mar 2015 | - | $842.60 K(+10.1%) |
| Dec 2014 | $3.91 M(+26.6%) | $765.10 K(-33.8%) |
| Sep 2014 | - | $1.16 M(+28.9%) |
| Jun 2014 | - | $896.50 K(-17.8%) |
| Mar 2014 | - | $1.09 M(+34.0%) |
| Dec 2013 | $3.09 M(+32.5%) | $813.70 K(-17.4%) |
| Sep 2013 | - | $985.50 K(+78.3%) |
| Jun 2013 | - | $552.80 K(-24.7%) |
| Mar 2013 | - | $734.00 K(+27.4%) |
| Dec 2012 | $2.33 M(-9.2%) | $576.20 K(+7.0%) |
| Sep 2012 | - | $538.60 K(-7.7%) |
| Jun 2012 | - | $583.50 K(-7.4%) |
| Mar 2012 | - | $630.30 K(-11.2%) |
| Dec 2011 | $2.57 M(+33.8%) | $709.80 K(+18.1%) |
| Sep 2011 | - | $600.80 K(-3.2%) |
| Jun 2011 | - | $620.70 K(-2.1%) |
| Mar 2011 | - | $634.30 K(+193.4%) |
| Dec 2010 | $1.92 M(-58.4%) | $216.20 K(-60.4%) |
| Sep 2010 | - | $545.90 K(-38.8%) |
| Jun 2010 | - | $892.10 K(+239.1%) |
| Mar 2010 | - | $263.10 K(-88.8%) |
| Dec 2009 | $4.61 M(+189.8%) | $2.35 M(+275.0%) |
| Sep 2009 | - | $626.00 K(+76.1%) |
| Jun 2009 | - | $355.50 K(-74.2%) |
| Mar 2009 | - | $1.38 M(+44.3%) |
| Dec 2008 | $1.59 M(+248.8%) | $953.50 K(+486.8%) |
| Sep 2008 | - | $162.50 K(-25.8%) |
| Jun 2008 | - | $218.90 K(-17.7%) |
| Mar 2008 | - | $266.10 K |
| Dec 2007 | $456.30 K | - |
FAQ
- What is OptimizeRx annual total operating expenses?
- What is the all time high annual operating expenses for OptimizeRx?
- What is OptimizeRx annual operating expenses year-on-year change?
- What is OptimizeRx quarterly total operating expenses?
- What is the all time high quarterly operating expenses for OptimizeRx?
- What is OptimizeRx quarterly operating expenses year-on-year change?
What is OptimizeRx annual total operating expenses?
The current annual operating expenses of OPRX is $60.42 M
What is the all time high annual operating expenses for OptimizeRx?
OptimizeRx all-time high annual total operating expenses is $60.42 M
What is OptimizeRx annual operating expenses year-on-year change?
Over the past year, OPRX annual total operating expenses has changed by +$9.16 M (+17.88%)
What is OptimizeRx quarterly total operating expenses?
The current quarterly operating expenses of OPRX is $14.52 M
What is the all time high quarterly operating expenses for OptimizeRx?
OptimizeRx all-time high quarterly total operating expenses is $19.86 M
What is OptimizeRx quarterly operating expenses year-on-year change?
Over the past year, OPRX quarterly total operating expenses has changed by +$1.17 M (+8.74%)